Table 3 Clinicopathological features of patients with PROM1 and CRTC2 mutations
From: Identification and validation of PROM1 and CRTC2 mutations in lung cancer patients
Patient | Gender | Age (yrs.) | Type | T | N | M | Stage | Differentiation | Tumor size (cm) | Family history | Smoking status | Pack years |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PROM1 | ||||||||||||
LCa-15 | M | 58 | ADC | 1a | 0 | 0 | IA | Poor | 1.2 × 1 × 0.8 | No | Never |  |
LC-116 | M | 70 | SCC | 4 | 0 | 0 | IIIA | Poor-moderate | 13.5 × 12 × 6 | Yes | Current | 182 |
LC-122 | F | 59 | ADC | 2a | 1 | 1b | IV | Poor | 4.3 × 2.3 × 3 | No | Never |  |
LC-215 | M | 68 | SCC | 2b | 1 | 0 | IIB | Poor | 6.1 × 4.9 × 5 | No | Current | 546 |
LC-275 | F | 54 | ADC | 4 | 2 | 1a | IV | Poor | 17 × 11 × 4.1 | No | Never |  |
LCTb-17 | M | 58 | ADC | 2a | 1 | 0 | IIA | Moderate | 4 × 3.5 × 3.5 | No | Current | 182 |
LCT-51 | M | 61 | SCC | 1a | 0 | 0 | IA | Poor | 2 × 1.5 × 1.4 | No | Current | 364 |
LCT-181 | F | 56 | ADC | 2a | 1 | 0 | IIA | Moderate-well | 4 × 3 × 3 | No | Never |  |
CRTC2 | ||||||||||||
LC-207 | M | 72 | ADC | 2a | 0 | 0 | IB | Moderate | 2.3 × 3.4 × 2 | No | Current | 365 |
LC-250 | F | 65 | ADC | 2a | 1 | 0 | IIA | Poor-moderate | 4 × 4 × 3.5 | No | Never |  |
LCT-81 | F | 57 | ADC | 2a | 0 | 0 | IB | Poor-moderate | 3 × 2.5 × 2.5 | No | Never |  |
LCT-94 | M | 69 | SCC | 1b | 0 | 0 | IA | Poor | 2.5 × 1.5 × 1.0 | No | Current | 500 |
LCT-111 | M | 52 | SCC | 2a | 1 | 0 | IIA | Poor-moderate | 4 × 3.5 × 2.5 | No | Current | 280 |
LCT-160 | M | 41 | ADC | 2a | 1 | 0 | IIA | Moderate | 4 × 3.5 × 4 | Yes | Never |  |
LCT-171 | F | 69 | ADC | 2a | 0 | 0 | IB | Poor-moderate | 4 × 4 × 3 | No | Never |  |